Will make profit of Rs 31 on each Rs 251 Smartphone: Mohit Goel

February 22, 2016

New Delhi, Feb 22: Since he announced the launch of a mobile phone for Rs 251, Mohit Goel has faced widespread scepticism, along with visits by police and income tax officials at his rented two-storey office in Noida. However, the Amity University graduate insists that he will not only deliver the phones at the stunning price he has quoted, but also make a profit of Rs 31 on each handset sold.

mohith1"Why am I being hounded? What wrong have I done?" Goel asked in the course of an exclusive interview with TOI. The director of Ringing Bells insists that his new venture is not a fly-by-night operation and will begin customer deliveries from April 15. "Has there ever been a case of income-tax evasion against me or my company, or has there been an FIR filed against me in any police station? Why am I being called a 'bhagora' (who'll run away with the money)? I intend to do a valid business, just like any other startup, and I have a business plan ready."

The company claims it has received over 7 crore registrations on its website since it started accepting applications on February 18. "We are taking online bookings for only 25 lakh units in the first batch due to limited supplies, while giving another 25 lakh through offline distributors. I will deliver the handsets before June 30. All the money that we receive from customers through the payment gateway will be kept in an escrow account and we will touch it only when we deliver the devices." The company has an account with ICICI Bank.

Goel, and his much-older confidant Ashok Chadha, who is the president of the company, insists that there have not been any infringements on design and other matters. "Some of the devices had the Adcom branding as we sourced panel (screen) from them. However, the final device will have our branding and the phone will have the same features and design that we had showcased."

The dual SIM Freedom 251 device carries a 4-inch display, 1 GB RAM, 8GB internal memory with a 1.3 GHZ quad-core processor, dual cameras and comes with a charger, headphone and one-year warranty.

The duo say that they have a carefully laid-out business model to manage the disruptive price for the device "The price that works out per device is roughly around Rs 1,500," Chadha says. insists, though significantly lowering it down from the Rs 2,500 he had announced on the day of the unveiling of the device. "We will source the devices from a supplier in Noida, who will be assembling the units for us after getting components from Taiwan." And while we do this, we also start the work to identify land and suppliers for setting up our manufacturing locations. For this, we have identified Noida while also looking at locations in Uttarakhand, West Bengal, Bihar and Punjab," Chadha says.

And just how does he bring down the cost to Rs 251, and also earn a profit? "Economies of scale gets it down to around Rs 1,200, and thereafter an online sales model cuts down marketing and sales expenses, giving us further savings," he says. And to this we will add marketing piggybacks from companies whose applications we load on the devices. We will save around Rs 300 per device more through this," Chadha says.

The unveiling of the phone on February 17 had created quite a flutter among existing handset suppliers, prompting industry body Indian Cellular Association to file a complaint with the government. (ICA) - which has members such as Samsung, Apple, Sony, Lava, Micromax, Karbonn, Motorola and HTC - ICA president Pankaj Mohindroo wrote a letter to telecom minister Ravi Shankar Prasad, expressing doubts about the intentions of Ringing Bells, saying it is not possible to supply a phone for Rs 251. Also, there were allegations that the company had ripped off the design of the prototype from American phone major Apple's iPhone, while also giving out devices sourced from a local electronics importer Adcom.

The company is also talking to large e-commerce companies, such as travel website Goibibo, to get their apps on the devices. "We will also monetize from the heavy traffic on our website and will make it into a marketplace for other brands to hop on. This will also help us to bring down the cost."

Comments

rampa
 - 
Monday, 22 Feb 2016

I think battery only original.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
May 22,2020

Mangaluru/Udupi, May 22: Two prominent Qadhis of coastal Karnataka today declared that Eid al-Fitr will be observed in the region on Sunday, May 24.

Twaqa Ahmed Musliyar, the Qadhi of Mangaluru and Ibrahim Musliyar Bekal, Qadhi of Udupi Samyukta Jamaat in their separate statements made this announcement. 

The decision was taken as there was no news of new moon sighting in the coastal region today.

Ullal Qadhi Qurrathussadath Seyyid Fazal Koyamma Thangal Al Bukhari also announced that 24th May is first of Shawwal and Eid al Fithr will be celebrated on that day.

Comments

GKS
 - 
Saturday, 23 May 2020

Moon sighting for the start of the month of Ramazan, for end of fastings- Eidul Fitr, for the month of Hajj and Muharram:

The moon sighting is so easy. We the people of India and have Indian Standard Time all.over India. 

When we can accept the moon sighting in Delhi and announcement from Delhi as it was during times of Radio and Doordarshan news, why can we not accept the sighting of moon in coastal region of Karnataka and in Kerala?

Let us bring about change for good.

GKS
 - 
Saturday, 23 May 2020

Why is rest of Karnataka or India not joining for Eid with coastal region and kerala? At the time of Radio and Dorrdarshan only days, all of India used to wait for 8.00 pm news for updates of moon sighting. So why not accept the moon signing witnesses in Kerala or coastal region?

 

I request all Indians to accept the witnessing of Moon sighting in any area of India and start and end Fasting. 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Mangaluru, Apr 4: Dakshina Kannada district deputy commissioner (DC) Sindhu B Rupesh in an official reminder has ordered milk unions to disburse about 5,000 litres of milk to residents of notified and non-notified slums, construction labourers and migrant labourers and their families in shelters in the district.

A decision regarding the free distribution of milk to such needy families was taken in a meeting by the chief minister on April 1.

The DC has ordered cooperative milk unions in the district to distribute milk to such families from April 4 till April 14.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.